Home > Healthcare > Medical Devices > Therapeutic Devices > lipid nanoparticle raw materials market
Get a free sample of Lipid Nanoparticle Raw Materials Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Lipid Nanoparticle Raw Materials Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Advancements in drug delivery have empowered the creation of lipid nanoparticles boasting superior attributes such as stability, biocompatibility, and targeted delivery. These enhancements are made possible by employing advanced lipid materials such as phospholipids, cholesterol, and diverse surfactants
.
North America lipid nanoparticle raw materials industry reached USD 92.5 million in 2023 and is expected to register a commendable CAGR from 2024-2032 due to the rising incidence of chronic ailments like cancer and diabetes in the region.
Biopharma PEG Scientific Inc., BroadPharm, CordenPharma, Creative Biolabs, Croda International Plc, Echelon Biosciences, Merck KGaA, NOF Corporation, Polysciences, Inc., and Tebubio, are some of the major lipid nanoparticle raw materials companies worldwide.
Lipid nanoparticle raw materials industry from the kits segment is expected to reach USD 195.1 million by 2032 due to a rising demand for specialized lipid components such as ionizable lipids, PEGylated lipids, sterol lipids, and neutral phospholipids, essential for formulating lipid nanoparticles.
Lipid nanoparticle raw materials market size was USD 227.4 million in 2023 and is expected to register 5.7% CAGR from 2024-2032 owing to the rise in chronic diseases such as cancer, diabetes, and cardiovascular disorders worldwide.